SID 2026Abstract 0507
A pilot study evaluating preliminary efficacy of deucravacitinib compared to placebo in the treatment of moderate-to-severe hidradenitis suppurativa (HS)
Tehrani MD, Porter ML, Ashina N, Wafae B, Tran T, Truong H, Sweet W, Gao JL, Salian P, Kimball AB
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Hidradenitis suppurativa
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.538 · Not in PubMed: details from Crossref